Sustained Improvements in Readings in-Range Using an Advanced Bluetooth® Connected Blood Glucose Meter and a Mobile Diabetes App: Real-World Evidence from more than 55,000 People with Diabetes-Reference-Cited by-同舟云学术

Sustained Improvements in Readings in-Range Using an Advanced Bluetooth® Connected Blood Glucose Meter and a Mobile Diabetes App: Real-World Evidence from more than 55,000 People with Diabetes

Published:2023-05-03 Issue:6 Volume:14 Page:1023-1035
ISSN:1869-6953
Container-title:Diabetes Therapy
language:en
Short-container-title:Diabetes Ther

Author:

Grady Mike^ORCID,Cameron Hilary,Holt Elizabeth^ORCID

Funder

LifeScan

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://link.springer.com/content/pdf/10.1007/s13300-023-01415-3.pdf

Reference35 articles.

1. Chircop J, Sheffield D, Kotera Y. Systematic review of self-monitoring of blood glucose in patients with type 2 diabetes. Nurs Res. 2021. https://doi.org/10.1097/NNR.0000000000000542.

2. Fang M, Wang D, Coresh J, Selvin E. Trends in diabetes treatment and control in U.S., adults 1999–2018. N Engl J Med. 2021;384:2219–28. https://doi.org/10.1056/NEJMsa2032271.

3. Kruger DF, Anderson JE. Continuous Glucose Monitoring (CGM) is a tool, not a reward: unjustified insurance coverage criteria limit access to CGM. Diabetes Technol Ther. 2021. https://doi.org/10.1089/dia.2021.0193.

4. Beck R, Riddlesworth TD, Ruedy K, et al. Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: the DIAMOND randomized clinical trial. JAMA. 2017;317(4):371–8. https://doi.org/10.1001/jama.2016.19975.

5. Beck R, Riddlesworth TD, Ruedy K, et al. Continuous glucose monitoring versus usual care in patients with type 2 diabetes receiving multiple daily insulin injections: a randomized trial. Ann Intern Med. 2017;167(6):365–74. https://doi.org/10.7326/M16-2855.